European Wax Center, Inc.
EWCZ scores 34.5 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.
Moderate penalties (-5.2 points) reflect identified risk factors. The overall score balances these against the stock's fundamental strengths.
These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.
| Stock | Score | P/E | Rev Growth | Margin | Mkt Cap |
|---|---|---|---|---|---|
| EWCZ | 34.5 | 22.1 | -1.9% | 5.3% | $313M |
| MNST | 84.4 | 46.3 | 4.9% | 20.1% | $84.6B |
| COCO | 77.4 | 43.1 | 18.2% | 11.7% | $3.3B |
| CALM | 76.7 | 3.5 | 83.2% | 27.4% | $4.1B |
| LAUR | 76.3 | 25.8 | 5.5% | 18.9% | $4.9B |
| WMT | 71.5 | 46.7 | 5.1% | 2.9% | $1.0T |
| CCEP | 68.9 | 25.1 | 11.7% | 6.9% | $49.7B |
| PSMT | 66.5 | 31.5 | 7.2% | 2.7% | $4.8B |
| COST | 66.2 | 54.6 | 8.2% | 2.9% | $441.9B |
| PEP | 65.1 | 27.6 | 2.3% | 8.8% | $230.9B |
| COKE | 64.6 | 23.1 | 3.7% | 9.2% | $16.7B |
| PRDO | 64.0 | 13.1 | 24.2% | 18.9% | $2.2B |
| SFD | 63.8 | 11.3 | -3.4% | 5.5% | $9.6B |
| OLLI | 62.5 | 31.4 | 8.0% | 8.8% | $6.7B |
| FIZZ | 61.2 | 18.6 | 0.8% | 15.6% | $3.5B |
| DLTR | 61.0 | 23.9 | 4.8% | 5.9% | $25.7B |
| Sector Average | 51.1 | 33.1 | 10.6% | -3.2% | โ |
European Wax Center, Inc. operates as the franchisor and operator of out-of-home waxing services in the United States. The company offers body and facial waxing services; and pre- and post-service products, including ingrown hair serums, exfoliating gels, brow shapers, and skin treatments. As of March 26, 2022, it had a portfolio of centers operating in 874 locations across 44 states, including 868 franchised centers and six corporate-owned centers. European Wax Center, Inc. was founded in 2004 and is headquartered in Plano, Texas.
Stock is losing momentum near highs. The 200-day SMA is flattening or beginning to turn. Historically, this stage precedes distribution.
Stage 3 distribution โ institutional selling pressure is building. Avoid new positions. If already holding, consider reducing and tightening stops below SMA50.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $54M | $56M | $51M | $50M |
| Gross Profit | $35M | $37M | $38M | $37M |
| Operating Income | $14M | $14M | $11M | $13M |
| Net Income | $4M | $4M | $2M | $2M |
| EPS (Diluted) | $0.09 | $0.09 | $0.04 | $0.04 |
| Gross Margin | 64.0% | 65.7% | 74.2% | 74.3% |
| Operating Margin | 25.9% | 25.2% | 20.6% | 25.8% |
| Net Margin | 7.0% | 6.7% | 3.4% | 4.0% |
| Year | Low | High | Range | Status |
|---|---|---|---|---|
| 2021 | $18.55 | $34.67 | 60.6% | Wide |
| 2022 | $12.02 | $33.31 | 93.9% | Wide |
| 2023 | $11.97 | $20.70 | 53.4% | Wide |
| 2024 | $4.80 | $16.07 | 108% | Wide |
| 2025 | $2.72 | $7.60 | 94.6% | Wide |
Growth estimates have been dampened based on technical and fundamental signals. This is a post-hoc adjustment to prevent overly optimistic projections for stocks showing declining momentum or deteriorating fundamentals.
Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.